A detailed history of Jennison Associates LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 1,237,430 shares of PCVX stock, worth $107 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,237,430
Previous 1,383,131 10.53%
Holding current value
$107 Million
Previous $104 Million 35.27%
% of portfolio
0.09%
Previous 0.07%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$70.52 - $117.12 $10.3 Million - $17.1 Million
-145,701 Reduced 10.53%
1,237,430 $141 Million
Q2 2024

Aug 05, 2024

BUY
$60.06 - $78.77 $7.58 Million - $9.94 Million
126,248 Added 10.04%
1,383,131 $104 Million
Q1 2024

May 02, 2024

SELL
$59.79 - $81.05 $13.1 Million - $17.8 Million
-219,271 Reduced 14.85%
1,256,883 $85.9 Million
Q4 2023

Feb 01, 2024

SELL
$45.35 - $63.41 $12.6 Million - $17.7 Million
-278,537 Reduced 15.87%
1,476,154 $92.7 Million
Q3 2023

Oct 31, 2023

BUY
$46.0 - $53.1 $13.8 Million - $15.9 Million
300,189 Added 20.64%
1,754,691 $89.5 Million
Q2 2023

Aug 03, 2023

BUY
$34.66 - $54.07 $847,887 - $1.32 Million
24,463 Added 1.71%
1,454,502 $72.6 Million
Q1 2023

Apr 26, 2023

BUY
$36.27 - $47.2 $291,320 - $379,110
8,032 Added 0.56%
1,430,039 $53.6 Million
Q4 2022

Feb 09, 2023

BUY
$20.58 - $47.95 $29.3 Million - $68.2 Million
1,422,007 New
1,422,007 $68.2 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.13B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.